0001493152-22-026582.txt : 20220922
0001493152-22-026582.hdr.sgml : 20220922
20220922173835
ACCESSION NUMBER: 0001493152-22-026582
CONFORMED SUBMISSION TYPE: 3
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20220920
FILED AS OF DATE: 20220922
DATE AS OF CHANGE: 20220922
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Liu James Yang
CENTRAL INDEX KEY: 0001944774
FILING VALUES:
FORM TYPE: 3
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37648
FILM NUMBER: 221260190
MAIL ADDRESS:
STREET 1: C/O ONCOCYTE CORPORATION
STREET 2: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Oncocyte Corp
CENTRAL INDEX KEY: 0001642380
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 271041563
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
BUSINESS PHONE: 949-409-7600
MAIL ADDRESS:
STREET 1: 15 CUSHING
CITY: IRVINE
STATE: CA
ZIP: 92618
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20200213
FORMER COMPANY:
FORMER CONFORMED NAME: Oncocyte Corp
DATE OF NAME CHANGE: 20200205
FORMER COMPANY:
FORMER CONFORMED NAME: OncoCyte Corp
DATE OF NAME CHANGE: 20150513
3
1
ownership.xml
X0206
3
2022-09-20
0
0001642380
Oncocyte Corp
OCX
0001944774
Liu James Yang
15 CUSHING
IRVINE
CA
92618
0
1
0
0
Controller, PAO
Option to Purchase Common Stock
1.15
2032-03-15
Common Stock
10000
D
Option to Purchase Common Stock
1.39
2032-03-24
Common Stock
2260
D
Option to Purchase Common Stock
0.887
2032-09-20
Common Stock
75000
D
25% of the options will become exercisable after one year of Reporting Person's continuous employment with Issuer from the effective date of grant, and the balance will become exercisable in 36 equal monthly installments commencing one year after the date of grant subject to Reporting Person's continued employment with Issuer on the applicable vesting dated.
/s/ James Liu
2022-09-22